rs587779195

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong

The NM_000251.3(MSH2):​c.942+2T>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.00096 ( 0 hom., cov: 11)
Exomes 𝑓: 0.0000071 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MSH2
NM_000251.3 splice_donor, intron

Scores

5
1
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 7.70

Publications

7 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.053475935 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PP5
Variant 2-47414420-T-A is Pathogenic according to our data. Variant chr2-47414420-T-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 428474.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.942+2T>A
splice_donor intron
N/ANP_000242.1P43246-1
MSH2
NM_001406674.1
c.942+2T>A
splice_donor intron
N/ANP_001393603.1
MSH2
NM_001406631.1
c.942+2T>A
splice_donor intron
N/ANP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.942+2T>A
splice_donor intron
N/AENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.942+2T>A
splice_donor intron
N/AENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.993+2T>A
splice_donor intron
N/AENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.000964
AC:
60
AN:
62212
Hom.:
0
Cov.:
11
show subpopulations
Gnomad AFR
AF:
0.00155
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000242
Gnomad ASJ
AF:
0.00113
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00315
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000684
Gnomad OTH
AF:
0.00386
GnomAD4 exome
AF:
0.00000713
AC:
7
AN:
982170
Hom.:
0
Cov.:
18
AF XY:
0.00000615
AC XY:
3
AN XY:
488162
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
21594
American (AMR)
AF:
0.0000535
AC:
1
AN:
18678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14772
East Asian (EAS)
AF:
0.00
AC:
0
AN:
23652
South Asian (SAS)
AF:
0.00
AC:
0
AN:
57452
European-Finnish (FIN)
AF:
0.0000932
AC:
2
AN:
21458
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2504
European-Non Finnish (NFE)
AF:
0.00000383
AC:
3
AN:
783500
Other (OTH)
AF:
0.0000259
AC:
1
AN:
38560
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.318
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000964
AC:
60
AN:
62212
Hom.:
0
Cov.:
11
AF XY:
0.00102
AC XY:
28
AN XY:
27556
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00155
AC:
30
AN:
19358
American (AMR)
AF:
0.000242
AC:
1
AN:
4136
Ashkenazi Jewish (ASJ)
AF:
0.00113
AC:
2
AN:
1768
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1634
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1108
European-Finnish (FIN)
AF:
0.00315
AC:
2
AN:
634
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
102
European-Non Finnish (NFE)
AF:
0.000684
AC:
22
AN:
32184
Other (OTH)
AF:
0.00386
AC:
3
AN:
778
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.350
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
Hereditary cancer-predisposing syndrome (3)
2
-
-
Lynch syndrome 1 (2)
1
-
-
Hereditary nonpolyposis colorectal neoplasms (1)
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.35
CADD
Pathogenic
32
DANN
Uncertain
0.99
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.88
FATHMM_MKL
Pathogenic
1.0
D
PhyloP100
7.7
GERP RS
4.7
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.93
SpliceAI score (max)
1.0
Details are displayed if max score is > 0.2
DS_DL_spliceai
1.0
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587779195; hg19: chr2-47641559; API